English
Insider transactions
EDGARVOR BIOPHARMA INC.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-18.
- Open-market purchases (code P)
- 0 transactions, — shares
- Open-market sales (code S)
- 16 transactions, 3,003,116 shares
- Sum of shares × price per share: 49,419,524.65
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–42 of 42
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-02 Filed 2026-11-04 | Sokolove Jeremy Brett Officer: Chief Medical Officer | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 1,917 | 19.25 | 36,902.25Derived: shares × price per share. Exact value 36902.25. | 25,983 | Direct (D) | No | F1
| Open filing 0001193125-26-447946 Read from the filing’s XML Dispute this row |
| 2026-10-02 Filed 2026-10-05 | RA CAPITAL MANAGEMENT, L.P. 10% ownerRA Capital Healthcare Fund LP 10% ownerKolchinsky Peter 10% ownerShah Rajeev M. 10% owner | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 500 | 12.80 | 6,400Derived: shares × price per share. Exact value 6400.00. | 500 | Indirect (I) See footnotes | No | F1, F2
| Open filing 0001231919-26-001426 Read from the filing’s XML Dispute this row |
| 2026-10-02 Filed 2026-10-05 | RA CAPITAL MANAGEMENT, L.P. 10% ownerRA Capital Healthcare Fund LP 10% ownerKolchinsky Peter 10% ownerShah Rajeev M. 10% owner | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 500 | 0 | — | 0 | Indirect (I) See Footnotes | No | F5, F1, F2
| Open filing 0001231919-26-001426 Read from the filing’s XML Dispute this row |
| 2026-08-24 Filed 2026-08-26 | RA CAPITAL MANAGEMENT, L.P. 10% ownerRA Capital Healthcare Fund LP 10% ownerKolchinsky Peter 10% ownerShah Rajeev M. 10% owner | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 1,500 | 3.736 | 5,604Derived: shares × price per share. Exact value 5604.000. | 1,500 | Indirect (I) See footnotes | No | F1, F2, F3
| Open filing 0001231919-26-001102 Read from the filing’s XML Dispute this row |
| 2026-08-24 Filed 2026-08-26 | RA CAPITAL MANAGEMENT, L.P. 10% ownerRA Capital Healthcare Fund LP 10% ownerKolchinsky Peter 10% ownerShah Rajeev M. 10% owner | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 1,500 | 0 | — | 0 | Indirect (I) See Footnotes | No | F1, F5, F2, F3
| Open filing 0001231919-26-001102 Read from the filing’s XML Dispute this row |
| 2026-07-16 Filed 2026-07-21 | RA CAPITAL MANAGEMENT, L.P. 10% ownerRA Capital Healthcare Fund LP 10% ownerKolchinsky Peter 10% ownerShah Rajeev M. 10% owner | XExercise of in-the-money or at-the-money derivative security | Acquired (A) | 2,100,000 | 0.002 | 4,200Derived: shares × price per share. Exact value 4200.000. | 4,502,095 | Indirect (I) See footnotes | No | F1, F2, F3
| Open filing 0001231919-26-000776 Read from the filing’s XML Dispute this row |
| 2026-07-16 Filed 2026-07-21 | RA CAPITAL MANAGEMENT, L.P. 10% ownerRA Capital Healthcare Fund LP 10% ownerKolchinsky Peter 10% ownerShah Rajeev M. 10% owner | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 213 | 19.75 | 4,206.75Derived: shares × price per share. Exact value 4206.75. | 4,501,882 | Indirect (I) See footnotes | No | F1, F2, F3
| Open filing 0001231919-26-000776 Read from the filing’s XML Dispute this row |
| 2026-07-16 Filed 2026-07-21 | RA CAPITAL MANAGEMENT, L.P. 10% ownerRA Capital Healthcare Fund LP 10% ownerKolchinsky Peter 10% ownerShah Rajeev M. 10% owner | XExercise of in-the-money or at-the-money derivative security | Disposed (D) | 2,100,000 | 5 | 10,500,000Derived: shares × price per share. Exact value 10500000. | 7,900,000 | Indirect (I) See Footnotes | No | F4, F2, F3
| Open filing 0001231919-26-000776 Read from the filing’s XML Dispute this row |
| 2026-07-07 Filed 2026-07-09 | ZACCARDELLI DAVID Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 42,658 | 0 | — | 42,658 | Direct (D) | No | F1
| Open filing 0001193125-26-299665 Read from the filing’s XML Dispute this row |
| 2026-06-11 Filed 2026-06-12 | Namouni Fouad Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 56,549 | 0 | — | 56,549 | Direct (D) | No | F1
| Open filing 0001193125-26-270000 Read from the filing’s XML Dispute this row |
| 2026-06-11 Filed 2026-06-12 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 57,162 | 0 | — | 57,162 | Indirect (I) See Footnotes | No | F1, F2, F3
| Open filing 0001231919-26-000633 Read from the filing’s XML Dispute this row |
| 2026-06-11 Filed 2026-06-12 | Kalir Erez Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 57,162 | 0 | — | 57,162 | Direct (D) | No | F1
| Open filing 0001193125-26-269998 Read from the filing’s XML Dispute this row |
| 2026-06-11 Filed 2026-06-12 | Beckman Daniella Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 53,283 | 0 | — | 53,283 | Direct (D) | No | F1
| Open filing 0001193125-26-269996 Read from the filing’s XML Dispute this row |
| 2026-06-11 Filed 2026-06-12 | Levin Andrew David Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 57,162 | 0 | — | 57,162 | Direct (D) | No | F1, F2
| Open filing 0001193125-26-269994 Read from the filing’s XML Dispute this row |
| 2026-06-11 Filed 2026-06-12 | Cumbo Alexander Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 56,345 | 0 | — | 56,345 | Direct (D) | No | F1
| Open filing 0001193125-26-269997 Read from the filing’s XML Dispute this row |
| 2026-06-11 Filed 2026-06-12 | Joustra Wouter Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 57,162 | 0 | — | 57,162 | Direct (D) | No | F1
| Open filing 0001193125-26-269999 Read from the filing’s XML Dispute this row |
| 2026-06-11 Filed 2026-06-12 | Detheux Michel Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 57,162 | 0 | — | 57,162 | Direct (D) | No | F1
| Open filing 0001193125-26-270002 Read from the filing’s XML Dispute this row |
| 2026-04-22 Filed 2026-04-24 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 165,150 | 15.77 | 2,604,415.5Derived: shares × price per share. Exact value 2604415.50. | 2,402,095 | Indirect (I) See footnotes | No | F1, F2, F3
| Open filing 0001231919-26-000409 Read from the filing’s XML Dispute this row |
| 2026-04-20 Filed 2026-04-21 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 171,963 | 15.77 | 2,711,856.51Derived: shares × price per share. Exact value 2711856.51. | 2,567,245 | Indirect (I) See footnotes | No | F4, F2, F3
| Open filing 0001231919-26-000385 Read from the filing’s XML Dispute this row |
| 2026-04-17 Filed 2026-04-21 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 458,411 | 16.28 | 7,462,931.08Derived: shares × price per share. Exact value 7462931.08. | 2,739,208 | Indirect (I) See footnotes | No | F1, F2, F3
| Open filing 0001231919-26-000385 Read from the filing’s XML Dispute this row |
| 2026-04-15 Filed 2026-04-15 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 53,644 | 16.01 | 858,840.44Derived: shares × price per share. Exact value 858840.44. | 3,197,619 | Indirect (I) See footnotes | No | F5, F2, F3
| Open filing 0001231919-26-000355 Read from the filing’s XML Dispute this row |
| 2026-04-14 Filed 2026-04-15 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 153,735 | 15.97 | 2,455,147.95Derived: shares × price per share. Exact value 2455147.95. | 3,251,263 | Indirect (I) See footnotes | No | F4, F2, F3
| Open filing 0001231919-26-000355 Read from the filing’s XML Dispute this row |
| 2026-04-13 Filed 2026-04-15 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 530,610 | 16.15 | 8,569,351.5Derived: shares × price per share. Exact value 8569351.50. | 3,404,998 | Indirect (I) See footnotes | No | F1, F2, F3
| Open filing 0001231919-26-000355 Read from the filing’s XML Dispute this row |
| 2026-04-10 Filed 2026-04-10 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 828 | 15.75 | 13,041Derived: shares × price per share. Exact value 13041.00. | 3,935,608 | Indirect (I) See footnotes | No | F6, F2, F3
| Open filing 0001231919-26-000333 Read from the filing’s XML Dispute this row |
| 2026-04-09 Filed 2026-04-10 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 135,201 | 16.59 | 2,242,984.59Derived: shares × price per share. Exact value 2242984.59. | 3,936,436 | Indirect (I) See footnotes | No | F5, F2, F3
| Open filing 0001231919-26-000333 Read from the filing’s XML Dispute this row |
| 2026-04-08 Filed 2026-04-10 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 353,242 | 16.32 | 5,764,909.44Derived: shares × price per share. Exact value 5764909.44. | 4,202,499 | Indirect (I) See footnotes | No | F1, F2, F3
| Open filing 0001231919-26-000333 Read from the filing’s XML Dispute this row |
| 2026-04-08 Filed 2026-04-10 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 130,862 | 16.91 | 2,212,876.42Derived: shares × price per share. Exact value 2212876.42. | 4,071,637 | Indirect (I) See footnotes | No | F4, F2, F3
| Open filing 0001231919-26-000333 Read from the filing’s XML Dispute this row |
| 2026-04-06 Filed 2026-04-06 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 537,754 | 16.51 | 8,878,318.54Derived: shares × price per share. Exact value 8878318.54. | 4,607,244 | Indirect (I) See footnotes | No | F5, F2, F3
| Open filing 0001231919-26-000320 Read from the filing’s XML Dispute this row |
| 2026-04-06 Filed 2026-04-06 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 44,728 | 17.31 | 774,241.68Derived: shares × price per share. Exact value 774241.68. | 4,562,516 | Indirect (I) See footnotes | No | F6, F2, F3
| Open filing 0001231919-26-000320 Read from the filing’s XML Dispute this row |
| 2026-04-06 Filed 2026-04-06 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 6,775 | 18.50 | 125,337.5Derived: shares × price per share. Exact value 125337.50. | 4,555,741 | Indirect (I) See footnotes | No | F2, F3
| Open filing 0001231919-26-000320 Read from the filing’s XML Dispute this row |
| 2026-04-02 Filed 2026-04-06 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 258,475 | 18.23 | 4,711,999.25Derived: shares × price per share. Exact value 4711999.25. | 5,146,523 | Indirect (I) See footnotes | No | F1, F2, F3
| Open filing 0001231919-26-000320 Read from the filing’s XML Dispute this row |
| 2026-04-02 Filed 2026-04-06 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,525 | 19.06 | 29,066.5Derived: shares × price per share. Exact value 29066.50. | 5,144,998 | Indirect (I) See footnotes | No | F4, F2, F3
| Open filing 0001231919-26-000320 Read from the filing’s XML Dispute this row |
| 2025-12-18 Filed 2025-12-19 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Disposed (D) | 4,625,346 | 10.81 | 49,999,990.26Derived: shares × price per share. Exact value 49999990.26. | 5,404,998 | Indirect (I) See footnotes | No | F1, F2
| Open filing 0001231919-25-000644 Read from the filing’s XML Dispute this row |
| 2025-12-18 Filed 2025-12-19 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 3,000 | 0 | — | 3,000 | Indirect (I) See Footnotes | No | F3, F1, F4
| Open filing 0001231919-25-000644 Read from the filing’s XML Dispute this row |
| 2025-12-18 Filed 2025-12-19 | Levin Andrew David Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 3,000 | 0 | — | 3,000 | Direct (D) | No | F1, F2
| Open filing 0001867539-25-000006 Read from the filing’s XML Dispute this row |
| 2025-12-18 Filed 2025-12-19 | Joustra Wouter Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 3,000 | 0 | — | 3,000 | Direct (D) | No | F1
| Open filing 0001897813-25-000010 Read from the filing’s XML Dispute this row |
| 2025-12-05 Filed 2025-12-09 | Zuraw Qing Che Officer: Chief Development Officer | DDisposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | Disposed (D) | 218,652 | 0 | — | 0 | Direct (D) | No | F1, F2, F3
| Open filing 0002079210-25-000003 Read from the filing’s XML Dispute this row |
| 2025-12-05 Filed 2025-12-09 | Zuraw Qing Che Officer: Chief Development Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 218,652 | 0 | — | 218,652 | Direct (D) | No | F4, F2, F3
| Open filing 0002079210-25-000003 Read from the filing’s XML Dispute this row |
| 2025-12-05 Filed 2025-12-09 | Mahatme Sandesh Officer: CFO | DDisposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | Disposed (D) | 694,137 | 0 | — | 0 | Direct (D) | No | F1, F2
| Open filing 0001511034-25-000006 Read from the filing’s XML Dispute this row |
| 2025-12-05 Filed 2025-12-09 | Mahatme Sandesh Officer: CFO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 1,388,274 | 0 | — | 1,388,274 | Direct (D) | No | F3, F4
| Open filing 0001511034-25-000006 Read from the filing’s XML Dispute this row |
| 2025-12-05 Filed 2025-12-09 | Kress Jean-Paul Director · Officer: CEO and Chairman | DDisposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | Disposed (D) | 4,164,831 | 0 | — | 0 | Direct (D) | No | F1, F2, F3
| Open filing 0001654979-25-000006 Read from the filing’s XML Dispute this row |
| 2025-12-05 Filed 2025-12-09 | Kress Jean-Paul Director · Officer: CEO and Chairman | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 4,164,831 | 0 | — | 4,164,831 | Direct (D) | No | F4, F2, F3
| Open filing 0001654979-25-000006 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 8,793 filings read, the latest filed 2026-11-17. Prior quarter ending 2026-06-30: 9,164 filings read.
Showing 1–50 of 163
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| FMR LLC Partly reported under another manager | 6,759,007 SH | 128,961,854 dollars | Higher by 1,826,858 Prior quarter: 4,932,149 | Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row |
| TCG Crossover Management, LLC | 5,673,078 SH | 108,242,328 dollars | Unchanged Prior quarter: 5,673,078 | Open filing 0001214659-26-014306 Filed 2026-11-16 Dispute this row |
| RA CAPITAL MANAGEMENT, L.P. | 4,503,882 SH | 85,934,069 dollars | Higher by 2,101,787 Prior quarter: 2,402,095 | Open filing 0001104659-26-128411 Filed 2026-11-16 Dispute this row |
| FCPM III SERVICES B.V. Partly reported under another manager | 3,405,279 SH | 64,972,723 dollars | Lower by 712,075 Prior quarter: 4,117,354 | Open filing 0001193125-26-462149 Filed 2026-11-16 Dispute this row |
| BlackRock, Inc. Partly reported under another manager | 3,306,494 SH | 63,087,906 dollars | Lower by 161,613 Prior quarter: 3,468,107 | Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row |
| Venrock Adviser, LLC | 3,041,719 SH | 58,035,999 dollars | Unchanged Prior quarter: 3,041,719 | Open filing 0001615982-26-000019 Filed 2026-11-16 Dispute this row |
| Frazier Life Sciences Management, L.P. | 2,743,939 SH | 52,354,356 dollars | Higher by 200,000 Prior quarter: 2,543,939 | Open filing 0001892134-26-000007 Filed 2026-11-16 Dispute this row |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,035,477 SH | 38,836,901 dollars | Lower by 48,851 Prior quarter: 2,084,328 | Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row |
| STATE STREET CORP Partly reported under another manager | 1,969,801 SH | 37,583,803 dollars | Lower by 646,535 Prior quarter: 2,616,336 | Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row |
| Caligan Partners LP | 1,925,066 SH | 36,730,259 dollars | Unchanged Prior quarter: 1,925,066 | Open filing 0001420506-26-002879 Filed 2026-11-16 Dispute this row |
| GREAT POINT PARTNERS LLC Partly reported under another manager | 1,126,910 SH | 21,501,443 dollars | Lower by 573,090 Prior quarter: 1,700,000 | Open filing 0001172661-26-005345 Filed 2026-11-16 Dispute this row |
| MILLENNIUM MANAGEMENT LLC | 991,532 SH | 18,918,431 dollars | Higher by 563,465 Prior quarter: 428,067 | Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row |
| GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager | 979,890 SH | 18,701,443 dollars | Lower by 82,579 Prior quarter: 1,062,469 | Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row |
| Nantahala Capital Management, LLC | 931,644 SH | 17,775,768 dollars | Lower by 758,356 Prior quarter: 1,690,000 | Open filing 0001104659-26-127125 Filed 2026-11-13 Dispute this row |
| Paradigm Biocapital Advisors LP | 889,575 SH | 16,973,091 dollars | Lower by 860,425 Prior quarter: 1,750,000 | Open filing 0001855655-26-000020 Filed 2026-11-16 Dispute this row |
| FEDERATED HERMES, INC. Partly reported under another manager | 760,221 SH | 14,505,017 dollars | Not in the prior quarter’s filings read | Open filing 0001623632-26-001675 Filed 2026-11-12 Dispute this row |
| GOLDMAN SACHS GROUP INC Partly reported under another manager | 746,214 SH | 14,237,763 dollars | Higher by 417,322 Prior quarter: 328,892 | Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row |
| NAN FUNG TRINITY (HK) LTD | 721,550 SH | 13,767,174 dollars | Higher by 75,000 Prior quarter: 646,550 | Open filing 0001420506-26-002513 Filed 2026-11-06 Dispute this row |
| BOOTHBAY FUND MANAGEMENT, LLC | 646,521 SH | 12,335,621 dollars | Higher by 87,819 Prior quarter: 558,702 | Open filing 0001549230-26-000012 Filed 2026-11-16 Dispute this row |
| NEXTBio Capital Management LP | 620,931 SH | 11,847,363 dollars | Lower by 268,233 Prior quarter: 889,164 | Open filing 0001172661-26-004969 Filed 2026-11-13 Dispute this row |
| Rosalind Advisors, Inc. | 609,199 SH | 11,623,517 dollars | Lower by 39,401 Prior quarter: 648,600 | Open filing 0001622627-26-000034 Filed 2026-11-16 Dispute this row |
| UBS Group AG Partly reported under another manager | 583,666 SH | 11,136,347 dollars | Higher by 90,388 Prior quarter: 493,278 | Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row |
| MARSHALL WACE, LLP Partly reported under another manager | 560,715 SH | 10,698,439 dollars | Higher by 465,072 Prior quarter: 95,643 | Open filing 0001318757-26-000012 Filed 2026-11-13 Dispute this row |
| Vivo Capital, LLC | 550,358 SH | 10,500,831 dollars | Not in the prior quarter’s filings read | Open filing 0001213900-26-119459 Filed 2026-11-13 Dispute this row |
| AMERIPRISE FINANCIAL INC Partly reported under another manager | 537,150 SH | 10,248,822 dollars | Not in the prior quarter’s filings read | Open filing 0001193125-26-463125 Filed 2026-11-16 Dispute this row |
| ADAR1 Capital Management, LLC | 531,349 SH | 10,138,139 dollars | Lower by 149,277 Prior quarter: 680,626 | Open filing 0001940272-26-000033 Filed 2026-11-16 Dispute this row |
| CITADEL ADVISORS LLC Partly reported under another manager | 497,989 SH | 9,501,630 dollars | Higher by 337,575 Prior quarter: 160,414 | Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 490,000 SH | 9,349,200 dollars | Not in the prior quarter’s filings read | Open filing 0001172661-26-005200 Filed 2026-11-16 Dispute this row |
| FRANKLIN TEMPLETON INC Partly reported under another manager | 425,735 SH | 8,565,788 dollars | Not in the prior quarter’s filings read | Open filing 0000038777-26-000291 Filed 2026-11-12 Dispute this row |
| SPHERA FUNDS MANAGEMENT LTD. Partly reported under another manager | 383,417 SH | 7,315,596 dollars | Lower by 33,000 Prior quarter: 416,417 | Open filing 0001496201-26-000006 Filed 2026-11-16 Dispute this row |
| Integral Health Asset Management, LLC | 350,000 SH | 6,678,000 dollars | Not in the prior quarter’s filings read | Open filing 0001172661-26-005192 Filed 2026-11-16 Dispute this row |
| Point72 Asset Management, L.P. | 343,037 SH | 6,545,146 dollars | Not in the prior quarter’s filings read | Open filing 0000919574-26-008126 Filed 2026-11-16 Dispute this row |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 340,442 SH | 6,495,633 dollars | Higher by 219,044 Prior quarter: 121,398 | Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 333,308 SH | 6,359,517 dollars | Lower by 7,056 Prior quarter: 340,364 | Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row |
| BRAIDWELL LP | 319,308 SH | 6,092,397 dollars | Lower by 253,796 Prior quarter: 573,104 | Open filing 0001420506-26-002894 Filed 2026-11-16 Dispute this row |
| NORTHERN TRUST CORP Partly reported under another manager | 308,867 SH | 5,893,182 dollars | Lower by 19,875 Prior quarter: 328,742 | Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP Partly reported under another manager | 300,529 SH | 5,734,093 dollars | Higher by 284,075 Prior quarter: 16,454 | Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row |
| VANGUARD FIDUCIARY TRUST CO | 277,062 SH | 5,286,343 dollars | Lower by 23,642 Prior quarter: 300,704 | Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row |
| Eversept Partners, LP | 268,389 SH | 5,120,862 dollars | Higher by 118,708 Prior quarter: 149,681 | Open filing 0001697013-26-000007 Filed 2026-11-16 Dispute this row |
| Ikarian Capital, LLC | 250,000 SH | 4,770,000 dollars | Not in the prior quarter’s filings read | Open filing 0001420506-26-002881 Filed 2026-11-16 Dispute this row |
| D. E. Shaw Co., Inc. Partly reported under another manager | 243,226 SH | 4,640,752 dollars | Higher by 188,555 Prior quarter: 54,671 | Open filing 0001104659-26-128287 Filed 2026-11-16 Dispute this row |
| STEMPOINT CAPITAL LP | 200,836 SH | 3,831,951 dollars | Not in the prior quarter’s filings read | Open filing 0001420506-26-002774 Filed 2026-11-16 Dispute this row |
| DIADEMA PARTNERS LP Option: Call | 200,000 SH | 3,816,000 dollars | Not in the prior quarter’s filings read | Open filing 0001892688-26-000170 Filed 2026-11-16 Dispute this row |
| Woodline Partners LP | 194,242 SH | 3,706,137 dollars | Lower by 185,481 Prior quarter: 379,723 | Open filing 0001172661-26-005063 Filed 2026-11-16 Dispute this row |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP Option: Call Partly reported under another manager | 186,200 SH | 3,552,696 dollars | Not in the prior quarter’s filings read | Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row |
| AQR CAPITAL MANAGEMENT LLC Partly reported under another manager | 175,775 SH | 3,353,786 dollars | Not in the prior quarter’s filings read | Open filing 0001167557-26-000324 Filed 2026-11-16 Dispute this row |
| WELLINGTON MANAGEMENT GROUP LLP Partly reported under another manager | 136,603 SH | 2,606,385 dollars | Higher by 109,503 Prior quarter: 27,100 | Open filing 0000902219-26-000323 Filed 2026-11-16 Dispute this row |
| ExodusPoint Capital Management, LP | 131,545 SH | 2,509,879 dollars | Not in the prior quarter’s filings read | Open filing 0001736225-26-000013 Filed 2026-11-16 Dispute this row |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP Option: Put Partly reported under another manager | 130,600 SH | 2,491,848 dollars | Higher by 66,000 Prior quarter: 64,600 | Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row |
| AXIOM INVESTORS LLC /DE | 124,196 SH | 2,369,660 dollars | Higher by 32,091 Prior quarter: 92,105 | Open filing 0001109147-26-000007 Filed 2026-11-12 Dispute this row |
Managers in the prior quarter with no filing read for the latest
They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.
- Logos Global Management LP 650,000 SH
- Clearline Capital LP 285,276 SH
- Sixth Street Partners Management Company, L.P. 121,398 SH
- Jump Financial, LLC 70,889 SH
- Walleye Capital LLC 46,612 SH
- TWO SIGMA INVESTMENTS, LP 37,012 SH
- RENAISSANCE TECHNOLOGIES LLC 33,011 SH
- Jefferies Financial Group Inc. 32,663 SH
- Scientech Research LLC 18,828 SH
- Y-Intercept (Hong Kong) Ltd 17,238 SH
- FOX RUN MANAGEMENT, L.L.C. 15,301 SH
- NEW YORK STATE COMMON RETIREMENT FUND 14,300 SH
- EntryPoint Capital, LLC 10,785 SH
- Pacer Advisors, Inc. 815 SH
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 180 SH
- MERCER GLOBAL ADVISORS INC /ADV 68 SH
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. Common Stock, $0.0001 par value per share | 9.9 | 6,443,619.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0001738048-26-000098 Dispute this row |
| VHCP Co-Investment Holdings III, LLC Common Stock, $0.0001 par value per share | 9.9 | 6,443,619.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0001738048-26-000098 Dispute this row |
| Venrock Healthcare Capital Partners EG, L.P. Common Stock, $0.0001 par value per share | 9.9 | 6,443,619.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0001738048-26-000098 Dispute this row |
| VHCP Management III, LLC Common Stock, $0.0001 par value per share | 9.9 | 6,443,619.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0001738048-26-000098 Dispute this row |
| VHCP Management EG, LLC Common Stock, $0.0001 par value per share | 9.9 | 6,443,619.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0001738048-26-000098 Dispute this row |
| Nimish Shah Common Stock, $0.0001 par value per share | 9.9 | 6,443,619.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0001738048-26-000098 Dispute this row |
| Bong Y. Koh Common Stock, $0.0001 par value per share | 9.9 | 6,443,619.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0001738048-26-000098 Dispute this row |
| TCG Crossover GP II, LLC Common Stock, par value $0.0001 per share | 4.6 | 2,836,539 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0001193125-26-464010 Dispute this row |
| TCG Crossover Fund II, L.P. Common Stock, par value $0.0001 per share | 4.6 | 2,836,539 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0001193125-26-464010 Dispute this row |
| TCG Crossover GP III, LLC Common Stock, par value $0.0001 per share | 4.6 | 2,836,539 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0001193125-26-464010 Dispute this row |
| TCG Crossover Fund III, L.P. Common Stock, par value $0.0001 per share | 4.6 | 2,836,539 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0001193125-26-464010 Dispute this row |
| Chen Yu Common Stock, par value $0.0001 per share | 9.2 | 5,673,078 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0001193125-26-464010 Dispute this row |
| FMR LLC COMMON STOCK | 10.7 | 6,318,525.00 | 09/30/2026 Filed 2026-11-05 | SCHEDULE 13G/AAmendment 2 | Open filing 0000315066-26-002877 Dispute this row |
| Abigail P. Johnson COMMON STOCK | 10.7 | 6,318,525.00 | 09/30/2026 Filed 2026-11-05 | SCHEDULE 13G/AAmendment 2 | Open filing 0000315066-26-002877 Dispute this row |
| FMR LLC COMMON STOCK | 12.0 | 6,509,996.00 | 07/31/2026 Filed 2026-08-07 | SCHEDULE 13G/AAmendment 1 | Open filing 0000315066-26-002253 Dispute this row |
| Abigail P. Johnson COMMON STOCK | 12.0 | 6,509,996.00 | 07/31/2026 Filed 2026-08-07 | SCHEDULE 13G/AAmendment 1 | Open filing 0000315066-26-002253 Dispute this row |
| RA Capital Management, L.P. Common Stock, par value $0.0001 per share | 19.9 | 12,937,855.00 | 07/16/2026 Filed 2026-07-21 | SCHEDULE 13D/AAmendment 18 | Open filing 0001346824-26-000197 Dispute this row |
| Peter Kolchinsky Common Stock, par value $0.0001 per share | 19.9 | 12,937,855.00 | 07/16/2026 Filed 2026-07-21 | SCHEDULE 13D/AAmendment 18 | Open filing 0001346824-26-000197 Dispute this row |
| Rajeev Shah Common Stock, par value $0.0001 per share | 19.9 | 12,937,855.00 | 07/16/2026 Filed 2026-07-21 | SCHEDULE 13D/AAmendment 18 | Open filing 0001346824-26-000197 Dispute this row |
| RA Capital Healthcare Fund, L.P. Common Stock, par value $0.0001 per share | 19.9 | 12,931,166.00 | 07/16/2026 Filed 2026-07-21 | SCHEDULE 13D/AAmendment 18 | Open filing 0001346824-26-000197 Dispute this row |
| Frazier Life Sciences Public Fund, L.P. Common Stock, $0.0001 par value per share | 4.2 | 2,258,001.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001231919-26-000911 Dispute this row |
| FHMLSP, L.P. Common Stock, $0.0001 par value per share | 4.2 | 2,258,001.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001231919-26-000911 Dispute this row |
| FHMLSP, L.L.C. Common Stock, $0.0001 par value per share | 4.2 | 2,258,001.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001231919-26-000911 Dispute this row |
| Frazier Life Sciences XI, L.P. Common Stock, $0.0001 par value per share | 0.0 | 21,114.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001231919-26-000911 Dispute this row |
| FHMLS XI, L.P. Common Stock, $0.0001 par value per share | 0.0 | 21,114.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001231919-26-000911 Dispute this row |
| FHMLS XI, L.L.C. Common Stock, $0.0001 par value per share | 0.0 | 21,114.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001231919-26-000911 Dispute this row |
| Frazier Life Sciences XII, L.P. Common Stock, $0.0001 par value per share | 0.5 | 264,824.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001231919-26-000911 Dispute this row |
| FHMLS XII, L.P. Common Stock, $0.0001 par value per share | 0.5 | 264,824.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001231919-26-000911 Dispute this row |
| FHMLS XII, L.L.C. Common Stock, $0.0001 par value per share | 0.5 | 264,824.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001231919-26-000911 Dispute this row |
| Venrock Healthcare Capital Partners III, L.P. Common Stock, $0.0001 par value per share | 9.9 | 5,676,370.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 3 | Open filing 0001231919-26-000936 Dispute this row |
| VHCP Co-Investment Holdings III, LLC Common Stock, $0.0001 par value per share | 9.9 | 5,676,370.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 3 | Open filing 0001231919-26-000936 Dispute this row |
| Venrock Healthcare Capital Partners EG, L.P. Common Stock, $0.0001 par value per share | 9.9 | 5,676,370.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 3 | Open filing 0001231919-26-000936 Dispute this row |
| VHCP Management III, LLC Common Stock, $0.0001 par value per share | 9.9 | 5,676,370.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 3 | Open filing 0001231919-26-000936 Dispute this row |
| VHCP Management EG, LLC Common Stock, $0.0001 par value per share | 9.9 | 5,676,370.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 3 | Open filing 0001231919-26-000936 Dispute this row |
| Nimish Shah Common Stock, $0.0001 par value per share | 9.9 | 5,676,370.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 3 | Open filing 0001231919-26-000936 Dispute this row |
| Bong Y. Koh Common Stock, $0.0001 par value per share | 9.9 | 5,676,370.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 3 | Open filing 0001231919-26-000936 Dispute this row |
| Verve Capital Limited Common Stock, $0.0001 par value per share | 6.3 | 3,410,892.00 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 3 | Open filing 0002088344-26-000009 Dispute this row |
| FMR LLC COMMON STOCK | 9.1 | 4,932,149.00 | 06/30/2026 Filed 2026-08-06 | SCHEDULE 13G | Open filing 0000315066-26-002174 Dispute this row |
| Abigail P. Johnson COMMON STOCK | 9.1 | 4,932,149.00 | 06/30/2026 Filed 2026-08-06 | SCHEDULE 13G | Open filing 0000315066-26-002174 Dispute this row |
| BlackRock, Inc. Common Stock | 5.7 | 3,099,259 | 06/30/2026 Filed 2026-07-30 | SCHEDULE 13G | Open filing 0002012383-26-003175 Dispute this row |
| RA Capital Management, L.P. Common Stock, par value $0.0001 per share | 19.9 | 12,896,519.00 | 04/20/2026 Filed 2026-04-21 | SCHEDULE 13D/AAmendment 17 | Open filing 0001346824-26-000113 Dispute this row |
| Peter Kolchinsky Common Stock, par value $0.0001 per share | 19.9 | 12,896,519.00 | 04/20/2026 Filed 2026-04-21 | SCHEDULE 13D/AAmendment 17 | Open filing 0001346824-26-000113 Dispute this row |
| Rajeev Shah Common Stock, par value $0.0001 per share | 19.9 | 12,896,519.00 | 04/20/2026 Filed 2026-04-21 | SCHEDULE 13D/AAmendment 17 | Open filing 0001346824-26-000113 Dispute this row |
| RA Capital Healthcare Fund, L.P. Common Stock, par value $0.0001 per share | 19.9 | 12,889,830.00 | 04/20/2026 Filed 2026-04-21 | SCHEDULE 13D/AAmendment 17 | Open filing 0001346824-26-000113 Dispute this row |
| RA Capital Management, L.P. Common Stock, par value $0.0001 per share | 19.9 | 12,739,024.00 | 04/14/2026 Filed 2026-04-15 | SCHEDULE 13D/AAmendment 16 | Open filing 0001346824-26-000107 Dispute this row |
| Peter Kolchinsky Common Stock, par value $0.0001 per share | 19.9 | 12,739,024.00 | 04/14/2026 Filed 2026-04-15 | SCHEDULE 13D/AAmendment 16 | Open filing 0001346824-26-000107 Dispute this row |
| Rajeev Shah Common Stock, par value $0.0001 per share | 19.9 | 12,739,024.00 | 04/14/2026 Filed 2026-04-15 | SCHEDULE 13D/AAmendment 16 | Open filing 0001346824-26-000107 Dispute this row |
| RA Capital Healthcare Fund, L.P. Common Stock, par value $0.0001 per share | 19.9 | 12,732,418.00 | 04/14/2026 Filed 2026-04-15 | SCHEDULE 13D/AAmendment 16 | Open filing 0001346824-26-000107 Dispute this row |
| RA Capital Management, L.P. Common Stock, par value $0.0001 per share | 19.9 | 12,554,642.00 | 04/09/2026 Filed 2026-04-10 | SCHEDULE 13D/AAmendment 15 | Open filing 0001346824-26-000103 Dispute this row |
| Peter Kolchinsky Common Stock, par value $0.0001 per share | 19.9 | 12,554,642.00 | 04/09/2026 Filed 2026-04-10 | SCHEDULE 13D/AAmendment 15 | Open filing 0001346824-26-000103 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,360,287 filings read, dated 2004-06-14 to 2026-11-17: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 17,836 |
| 2016 | 222,374 |
| 2017 | 207,870 |
| 2018 | 222,268 |
| 2019 | 215,153 |
| 2020 | 157,831 |
| 2021 | 224,474 |
| 2022 | 158,941 |
| 2023 | 199,811 |
| 2024 | 209,823 |
| 2025 | 235,520 |
| 2026 | 260,174 |
Filings made before the SEC required XML are listed, not extracted.